Filing Details
- Accession Number:
- 0000899243-21-031137
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-02 21:20:25
- Reporting Period:
- 2021-07-30
- Accepted Time:
- 2021-08-02 21:20:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1786255 | Icosavax Inc. | ICVX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1874021 | Niranjan Kanesa-Thasan | C/O Icosavax, Inc. 1616 Eastlake Avenue E., Suite 208 Seattle WA 98102 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-02 | 6,666 | $15.00 | 6,666 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-30 | 41,500 | $15.00 | 168,656 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | A | Direct |
Footnotes
- Represents restricted stock units ("RSUs") granted on July 30, 2021, 25% of the total number of RSUs granted vest on each of the first four anniversaries of July 28, 2021, the vesting commencement date, subject to the reporting person's continued service on the applicable vesting date. Vesting of the RSUs shall accelerate as provided in the reporting person's offer letter. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
Billionaire Hedge Funds
